Intracranial Stents Market Projected to Achieve USD 3.4 billion by 2031, with a 5.2% CAGR Growth: Transparency Market Research, Inc. [Yahoo! Finance]
Penumbra, Inc. (PEN)
Last penumbra, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.penumbrainc.com/overview/default.aspx
Company Research
Source: Yahoo! Finance
intracranial stents market is expected to witness significant growth in the coming years. Wilmington, Delaware, United States, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global intracranial stents market is projected to grow at a CAGR of 5.2% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 3.4 billion is anticipated for the market in 2031. As of 2023, the demand for intracranial stents is expected to close at US$ 2.3 billion. The rising prevalence of conditions such as aneurysms, strokes, and intracranial stenosis worldwide is a significant driver for the market. As the population ages and lifestyle factors contribute to these conditions, the demand for intracranial stents as a treatment option is growing. The growing elderly population, along with an increase in chronic neurological diseases and heightened investment in research and development for stroke and chronic neurological disease management, are driving the demand
Show less
Read more
Impact Snapshot
Event Time:
PEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PEN alerts
High impacting Penumbra, Inc. news events
Weekly update
A roundup of the hottest topics
PEN
News
- Penumbra's (PEN) New Launch to Enhance Blood Clot Removal [Yahoo! Finance]Yahoo! Finance
- Here's Why Penumbra (PEN) is a Strong Growth Stock [Yahoo! Finance]Yahoo! Finance
- Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots [Yahoo! Finance]Yahoo! Finance
- Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood ClotsPR Newswire
- Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024PR Newswire
PEN
Earnings
- 2/22/24 - Beat
PEN
Sec Filings
- 4/24/24 - Form ARS
- 4/24/24 - Form DEFA14A
- 4/24/24 - Form DEF
- PEN's page on the SEC website